Ignite Creation Date:
2024-05-06 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03555877
Status:
COMPLETED
Last Update Posted:
2023-07-07
First Post:
2018-02-16
Brief Title:
Anti-hormonal Therapie With Ribociclib in HR-positive HER2- Negative Metastatic Breast Cancer
Sponsor:
German Breast Group
Organization:
German Breast Group
Organization Data
Organization:
German Breast Group
Class:
OTHER
Study ID:
GBG 97
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
German Breast Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None